TIMP3 and head and neck squamous cell carcinoma: We determined the amount of TACE and TIMP3 mRNA in human HNSCC using RNA in situ hybridisation as the method of choice, as published reports and own studies quantifying TACE protein levels using immunohistochemistry led to conflicting results, probably because of poorly characterised antibodies (Merchant et al, 2008).